Presently, over 160 innovative, software enabled systems are being used to efficiently manage by roots analysis

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.

• A detailed assessment of the current market landscape, featuring a comprehensive list of over 160 technological platforms that are being used to manage the cell and advanced therapies supply chain, along with information on the different types of software systems (COP, EMS, IMS, LIMS, LMS, PMS, QMS, TTS, and others), their key specifications and benefits (chain of identity and custody, compatibility and integration, data management and analytics, regulatory compliance, reliability and security, scalability, software-as-a-service, traceability, user-friendliness, workflow management, and others), affiliated modes of deployment (cloud and on-premises), scale of management (small enterprise, mid-size enterprise and large enterprise), end users (biobanks, cell therapy labs, hospitals, research institutes, commercial organizations, and others), applications (ordering and scheduling, sample collection, manufacturing, logistics, and patient verification and treatment follow-up), regulatory certifications / accreditations (21 CFR Part 11, CLIA, FACT-JACIE, GAMP 5, GDPR, HIPAA, and others), and key support services offered (customization, installation / implementation, maintenance, training / technical support, upgradation, validation and testing, and others).
• An insightful company competitiveness analysis, taking into consideration the supplier power (based on their employee base and years of experience in the industry) and portfolio-related parameters, such as number of software solutions offered, affiliated modes of deployment, scale of management, end users, applications, regulatory certifications / accreditations, support services offered, and key platform specifications and benefits.
• Comprehensive profiles of industry players that are currently offering software solutions for supply chain management, featuring an overview of the company, its financial information (if available), and a detailed description of its software system(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.
• A detailed review of the cell and advanced therapies supply chain, offering insights on the processes associated with various stages, such as donor eligibility assessment, sample collection, manufacturing, logistics, and patient verification and treatment follow-up, along with information on cost requirements and existing opportunities for improvement in the supply chain management practices.

 

To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this -

https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

 

The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chain management software solutions market has been analyzed across the following segments:

• Application area
• Sample collection and processing
• Manufacturing
• Logistics
• Patient identification and treatment follow-up

 

• Type of software solution
• Cell orchestration platform
• Enterprise manufacturing system
• Inventory management system
• Laboratory information management system
• Logistics management system
• Patient management system
• Quality management system

 

• Mode of Deployment
• Cloud-based solution
• On-premises solution

 

• Scale of Operation
• Clinical
• Commercial

 

• End user
• Biobank
• Cell therapy lab / commercial organization
• Hospital / medical center
• Research institute

 

• Key geographical regions
• North America
• Europe
• Asia Pacific

Rest of the world

 

The Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking & Tracing Systems, and Other Software), 2019-2030 report features the following companies, which we identified to be key players in this domain:

Be The Match BioTherapies®

• Brooks Life Sciences
• Clarkston Consulting
• Cryoport
• Haemonetics
• Hypertrust Patient Data Care
• Lykan Bioscience
• MAK-SYSTEM
• MasterControl
• SAP
• SAVSU Technologies
• sedApta Group
• Stafa Cellular Therapy
• Title21 Health Solutions
• TrakCel
• Vineti

 

Table of Contents

 

1.         Preface

2.         Executive Summary

 

3.         Introduction

 

4.         Current Market Landscape

 

5.         Company Competitiveness Analysis

 

6.         Cell and Advanced Therapies Supply Chain Management: Company Profiles

 

7.         Supply Chain Orchestration Platform: Emerging Trends and Key Players

 

8.         Funding and Investment Analysis

 

9.         Partnerships and Collaborations

 

10.       Supply Chain Utilization Use Cases

 

11.       Stakeholder Needs Analysis

 

12.       Cost Savings Analysis

 

13.       Market Forecast

 

14.       Executive Insights

 

15.       Concluding Remarks

 

16.       Appendix 1: List of Additional Supply Chain Management Software Solutions

 

17.       Appendix 2: Tabulated Data

 

18.       Appendix 3: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]